{"id":"W4318707901","doi":"10.3389/fonc.2022.1028825","title":"End-of-neoadjuvant treatment circulating microRNAs and HER2-positive breast cancer patient prognosis: An exploratory analysis from NeoALTTO","year":2023,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"Ministero della Salute; Novartis; GlaxoSmithKline","keywords":"Medicine; Oncology; Trastuzumab; Breast cancer; Internal medicine; Proportional hazards model; Hazard ratio; Neoadjuvant therapy; microRNA; Multivariate analysis; Confidence interval; Cancer; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006542114,0.0003603641,0.0004194365,0.0003777103,0.0002394742,0.0003497731,0.000271652,0.0002415479,0.001653384],"category_scores_gemma":[0.001210793,0.0001406506,0.0004737479,0.0001778559,0.0002748658,0.0002036505,0.0005952553,0.0003038435,0.0004264899],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002226444,"about_ca_system_score_gemma":0.0002595633,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003303851,"about_ca_topic_score_gemma":0.0007082479,"domain_scores_codex":[0.9997217,0.00009009656,0.00001784547,0.00006842494,0.00005390717,0.00004797567],"domain_scores_gemma":[0.9992126,0.000265026,0.0001434673,0.0001637662,0.00007334381,0.0001417288],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01711761,0.001491381,0.9410416,0.0001325946,0.0004405476,0.0006187292,0.0003674906,0.0009261732,0.0133668,0.0001154458,0.001148473,0.02323315],"study_design_scores_gemma":[0.0003905607,0.004186438,0.9828759,0.00002781494,0.0003567225,0.001927686,0.0002986395,0.002482406,0.003955117,0.0001712997,0.003305168,0.00002218053],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9988707,0.00007942635,0.0001554929,0.00001523154,0.000003631348,0.00002841738,0.0005231861,0.000005115038,0.000318711],"genre_scores_gemma":[0.9964166,0.00004630674,0.0003785421,0.00004241753,0.00001469508,0.0001032915,0.002582984,0.000006706893,0.000408474],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001653384,"threshold_uncertainty_score":0.005531073,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01151613694950658,"score_gpt":0.2758597328626889,"score_spread":0.2643435959131823,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}